These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Contact sensitivity to budesonide in a child. Auricchio L; Nino M; Suppa F Contact Dermatitis; 2000 Jun; 42(6):359. PubMed ID: 10871107 [No Abstract] [Full Text] [Related]
7. Contact allergy to budesonide and perforation of the nasal septum. Isaksson M; Bruze M; Wihl JA Contact Dermatitis; 1997 Sep; 37(3):133. PubMed ID: 9330826 [No Abstract] [Full Text] [Related]
8. Contact allergy to inhaled budesonide. García AP; Tovar V; de Barrio M; Villanueva A; Tornero P Contact Dermatitis; 2008 Jul; 59(1):60-1. PubMed ID: 18598312 [No Abstract] [Full Text] [Related]
9. Contact hypersensitivity to tixocortol pivalate. Lutz ME; el-Azhary RA; Gibson LE; Fransway AF J Am Acad Dermatol; 1998 May; 38(5 Pt 1):691-5. PubMed ID: 9591812 [TBL] [Abstract][Full Text] [Related]
10. [Systemic effect of nasal corticosteroids?]. Landerholm L; Mjörndal T Lakartidningen; 2006 Oct 18-24; 103(42):3208-9. PubMed ID: 17111993 [No Abstract] [Full Text] [Related]
12. Safety of long-term intranasal budesonide delivered via the mucosal atomization device for chronic rhinosinusitis. Manji J; Singh G; Okpaleke C; Dadgostar A; Al-Asousi F; Amanian A; Macias-Valle L; Finkelstein A; Tacey M; Thamboo A; Javer A Int Forum Allergy Rhinol; 2017 May; 7(5):488-493. PubMed ID: 28151588 [TBL] [Abstract][Full Text] [Related]
13. Cutaneous-mucosal allergic contact reaction due to topical corticosteroids. Gonzalo Garijo MA; Bobadilla González P Allergy; 1995 Oct; 50(10):833-6. PubMed ID: 8607567 [TBL] [Abstract][Full Text] [Related]
14. Exhaling a budesonide inhaler through the nose results in a significant reduction in dose requirement of budesonide nasal spray in patients having asthma with rhinitis. Shaikh WA J Investig Allergol Clin Immunol; 1999; 9(1):45-9. PubMed ID: 10212857 [TBL] [Abstract][Full Text] [Related]
15. Patch testing with budesonide in serial dilutions. A multicentre study of the EECDRG. Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Diepgen T; Ducomb G; Frosch PJ; Goossens A; Lahti A; Menné T; Seidenari S; Tosti A; Wahlberg J; Wilkinson JD Contact Dermatitis; 2000 Jun; 42(6):352-4. PubMed ID: 10871102 [No Abstract] [Full Text] [Related]
17. Patch testing with budesonide in serial dilutions: the significance of dose, occlusion time and reading time. Isaksson M; Bruze M; Goossens A; Lepoittevin JP Contact Dermatitis; 1999 Jan; 40(1):24-31. PubMed ID: 9928801 [TBL] [Abstract][Full Text] [Related]
18. Contact allergy to budesonide in a nasal spray. Faria A; Marote J; de Freitas C Contact Dermatitis; 1992 Jul; 27(1):57. PubMed ID: 1424598 [No Abstract] [Full Text] [Related]
19. Allergic contact dermatitis from 6alpha-methylprednisolone aceponate and budesonide. Corazza M; Virgili A Contact Dermatitis; 1998 Jun; 38(6):356-7. PubMed ID: 9687052 [No Abstract] [Full Text] [Related]
20. Topical corticosteroid allergy in an urban Australian centre. Keegel T; Saunders H; Milne R; Sajjachareonpong P; Fletcher A; Nixon R Contact Dermatitis; 2004 Jan; 50(1):6-14. PubMed ID: 15059096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]